Thymalin vs Pidotimod

Head-to-head comparison of Thymalin (Calf Thymus Peptide Fraction (Thymalin)) and Pidotimod (3-L-Pyroglutamyl-L-Thiazolidine-4-Carboxylic Acid) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyThymalinPidotimod
CategoryImmune SupportImmune Support
Full NameCalf Thymus Peptide Fraction (Thymalin)3-L-Pyroglutamyl-L-Thiazolidine-4-Carboxylic Acid
Molecular WeightN/A244.27 Da
Half-LifeN/A3-4 h
Amino AcidsN/A2
Typical Dose5-20 mg400-800 mg/day
RouteIntramuscularOral
Purity≥98%≥98%
Studies Count120200
Research StatusClinicalClinical

Thymalin Benefits

  • t-cell support
  • leukocyte recovery
  • immunomodulation
  • infection-resilience

Pidotimod Benefits

  • oral-immune-support
  • respiratory-infection-adjunct
  • innate-immunity
  • adaptive-immunity-support

Thymalin Dosing

5-10 mg IM daily|3-10 day cycles|repeat cycles after 1-4 weeks if studied

Pidotimod Dosing

400 mg PO BID|typically 15-30 days|repeated seasonal cycles in studies

Thymalin Side Effects

  • injection-site discomfort
  • transient fever
  • rash/allergy

Pidotimod Side Effects

  • nausea
  • diarrhea
  • rash

Research Overview

Thymalin

Thymalin appears in Soviet/Russian clinical literature as a thymus peptide complex used to normalize immune parameters after illness, surgery, or radiation exposure. Reports commonly focus on changes in lymphocyte subsets, phagocytic activity, and infection frequency rather than a single isolated peptide mechanism.

Pidotimod

Pidotimod has human data in recurrent infections, especially where immune stimulation or reduced infection frequency is the target. Published work commonly reports improvements in phagocyte function, mucosal defense, and fewer respiratory infection episodes.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Thymalin stacks with:

Vitamin DZincProbiotics

Pidotimod stacks with:

Vitamin DZincQuercetin
thymic-peptideimmunomodulatorclinical-literatureoral-immunomodulatordipeptide-derivativerespiratory-infection